Fois, A.G.; Sotgiu, E.; Scano, V.; Negri, S.; Mellino, S.; Zinellu, E.; Pirina, P.; Pintus, G.; Carru, C.; Mangoni, A.A.;
et al. Effects of Pirfenidone and Nintedanib on Markers of Systemic Oxidative Stress and Inflammation in Patients with Idiopathic Pulmonary Fibrosis: A Preliminary Report. Antioxidants 2020, 9, 1064.
https://doi.org/10.3390/antiox9111064
AMA Style
Fois AG, Sotgiu E, Scano V, Negri S, Mellino S, Zinellu E, Pirina P, Pintus G, Carru C, Mangoni AA,
et al. Effects of Pirfenidone and Nintedanib on Markers of Systemic Oxidative Stress and Inflammation in Patients with Idiopathic Pulmonary Fibrosis: A Preliminary Report. Antioxidants. 2020; 9(11):1064.
https://doi.org/10.3390/antiox9111064
Chicago/Turabian Style
Fois, Alessandro G., Elisabetta Sotgiu, Valentina Scano, Silvia Negri, Sabrina Mellino, Elisabetta Zinellu, Pietro Pirina, Gianfranco Pintus, Ciriaco Carru, Arduino A. Mangoni,
and et al. 2020. "Effects of Pirfenidone and Nintedanib on Markers of Systemic Oxidative Stress and Inflammation in Patients with Idiopathic Pulmonary Fibrosis: A Preliminary Report" Antioxidants 9, no. 11: 1064.
https://doi.org/10.3390/antiox9111064
APA Style
Fois, A. G., Sotgiu, E., Scano, V., Negri, S., Mellino, S., Zinellu, E., Pirina, P., Pintus, G., Carru, C., Mangoni, A. A., & Zinellu, A.
(2020). Effects of Pirfenidone and Nintedanib on Markers of Systemic Oxidative Stress and Inflammation in Patients with Idiopathic Pulmonary Fibrosis: A Preliminary Report. Antioxidants, 9(11), 1064.
https://doi.org/10.3390/antiox9111064
